DATE,PATIENT,ENCOUNTER,CODE,DESCRIPTION,BASE_COST
2016-01-30T16:43:22Z,80c84c68-9fb5-a76a-a7d3-3fb5c01201e5,5c7d5926-d511-a20a-c9cc-5583f4675616,140,Influenza  seasonal  injectable  preservative free,136.0
2016-01-30T16:43:22Z,80c84c68-9fb5-a76a-a7d3-3fb5c01201e5,5c7d5926-d511-a20a-c9cc-5583f4675616,113,Td (adult)  5 Lf tetanus toxoid  preservative free  adsorbed,136.0
2016-01-30T16:43:22Z,80c84c68-9fb5-a76a-a7d3-3fb5c01201e5,5c7d5926-d511-a20a-c9cc-5583f4675616,43,Hep B  adult,136.0
2016-01-30T16:43:22Z,80c84c68-9fb5-a76a-a7d3-3fb5c01201e5,5c7d5926-d511-a20a-c9cc-5583f4675616,114,meningococcal MCV4P,136.0
2019-02-02T16:43:22Z,80c84c68-9fb5-a76a-a7d3-3fb5c01201e5,bb631ec1-a693-da7f-33cf-dc84351db0d4,140,Influenza  seasonal  injectable  preservative free,136.0
2021-03-27T16:43:22Z,80c84c68-9fb5-a76a-a7d3-3fb5c01201e5,b34d4589-f76d-1af2-ae1a-79c7604c52a9,207,COVID-19  mRNA  LNP-S  PF  100 mcg/0.5mL dose or 50 mcg/0.25mL dose,136.0
2021-04-24T16:43:22Z,80c84c68-9fb5-a76a-a7d3-3fb5c01201e5,2bd88b88-1720-0431-35d4-cd7021de84bb,207,COVID-19  mRNA  LNP-S  PF  100 mcg/0.5mL dose or 50 mcg/0.25mL dose,136.0
2022-02-05T16:43:22Z,80c84c68-9fb5-a76a-a7d3-3fb5c01201e5,2d2f745c-7b09-8f2f-62e1-e45de9b511f0,140,Influenza  seasonal  injectable  preservative free,136.0
